181 related articles for article (PubMed ID: 3007321)
1. Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers.
Hamid QA; Bishop AE; Sikri KL; Varndell IM; Bloom SR; Polak JM
Histopathology; 1986 Feb; 10(2):119-33. PubMed ID: 3007321
[TBL] [Abstract][Full Text] [Related]
2. Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides.
Rindi G; Efrat S; Ghatei MA; Bloom SR; Solcia E; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):115-29. PubMed ID: 1678563
[TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
Drucker DJ; Asa SL; Silverberg J; Brubaker PL
Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
[TBL] [Abstract][Full Text] [Related]
4. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
[TBL] [Abstract][Full Text] [Related]
5. A malignant tumor of the pancreas producing glucagonoma syndrome: coexistence of glucagon and pancreatic polypeptide (PP) in the tumor cells.
Bani D; Bani Sacchi T; Biliotti G
Pancreas; 1989; 4(4):511-9. PubMed ID: 2548179
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours.
Bordi C; Pilato FP; D'Adda T
Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):387-98. PubMed ID: 2845642
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations.
Tomita T; Kimmel JR; Friesen SR; Doull V; Pollock HG
Cancer; 1985 Oct; 56(7):1649-57. PubMed ID: 2992743
[TBL] [Abstract][Full Text] [Related]
8. Electron microscopic and immunoelectron microscopic demonstration of pancreatic polypeptide cells in glucagonoma: colocalization of pancreatic peptide and glucagon in single secretory granules.
Ooi A; Katsuda S; Nakanishi I; Kameya T; Yamaguchi K; Kitamura H; Hayakawa Y
Ultrastruct Pathol; 1989; 13(1):15-22. PubMed ID: 2537546
[TBL] [Abstract][Full Text] [Related]
9. Glucagonomas. Ultrastructure and immunocytochemistry.
Warner TF; Block M; Hafez GR; Mack E; Lloyd RV; Bloom SR
Cancer; 1983 Mar; 51(6):1091-6. PubMed ID: 6295622
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin.
Viale G; Doglioni C; Gambacorta M; Zamboni G; Coggi G; Bordi C
Cancer; 1992 Nov; 70(9):2268-77. PubMed ID: 1356613
[TBL] [Abstract][Full Text] [Related]
11. Alpha-human chorionic gonadotropin and neuron-specific enolase as markers for malignancy and neuroendocrine nature of pancreatic endocrine tumors.
Klöppel G; Girard J; Polak JM; Vaitukaitis JL; Kasper M; Heitz PU
Cancer Detect Prev; 1983; 6(1-2):161-6. PubMed ID: 6309383
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical studies on glucagon, glicentin and pancreatic polypeptide in human stomach: normal and pathological conditions.
Tsutsumi Y
Histochem J; 1984 Aug; 16(8):869-83. PubMed ID: 6207142
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic endocrine tumours associated with WDHA syndrome. An immunohistochemical and electron microscopic study.
Ooi A; Kameya T; Tsumuraya M; Yamaguchi K; Abe K; Shimosato Y; Yanaihara N
Virchows Arch A Pathol Anat Histopathol; 1985; 405(3):311-23. PubMed ID: 2579503
[TBL] [Abstract][Full Text] [Related]
14. Isolation of human pancreastatin fragment containing the active sequence from a glucagonoma.
Sekiya K; Ghatei MA; Minamino N; Bretherton-Watt D; Matsuo H; Bloom SR
FEBS Lett; 1988 Feb; 228(1):153-6. PubMed ID: 2830133
[TBL] [Abstract][Full Text] [Related]
15. Secretory protein 7B2 is associated with pancreatic hormones within normal islets and some experimentally induced tumors.
Benjannet S; Marcinkiewicz M; Falgueyret JP; Johnson DE; Seidah NG; Chrétien M
Endocrinology; 1988 Aug; 123(2):874-84. PubMed ID: 2840270
[TBL] [Abstract][Full Text] [Related]
16. Binding of antibodies against human prealbumin to intestinal and bronchial carcinoids and to pancreatic endocrine tumours.
Bussolati G; Papotti M; Sapino A
Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 45(1):15-22. PubMed ID: 6142557
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry of pancreatic islet cell tumors in the ferret (Mustela putorius furo).
Andrews GA; Myers NC; Chard-Bergstrom C
Vet Pathol; 1997 Sep; 34(5):387-93. PubMed ID: 9381649
[TBL] [Abstract][Full Text] [Related]
18. MEN I pancreas: a histological and immunohistochemical study.
Thompson NW; Lloyd RV; Nishiyama RH; Vinik AI; Strodel WE; Allo MD; Eckhauser FE; Talpos G; Mervak T
World J Surg; 1984 Aug; 8(4):561-74. PubMed ID: 6207668
[No Abstract] [Full Text] [Related]
19. Expression of chromogranin A and B and secretoneurin immunoreactivity in neoplastic and nonneoplastic pancreatic alpha cells.
Schmid KW; Brink M; Freytag G; Kirchmair R; Böcker W; Fischer-Colbrie R; Heitz PU; Klöppel G
Virchows Arch; 1994; 425(2):127-32. PubMed ID: 7952497
[TBL] [Abstract][Full Text] [Related]
20. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
Powers AC; Efrat S; Mojsov S; Spector D; Habener JF; Hanahan D
Diabetes; 1990 Apr; 39(4):406-14. PubMed ID: 2156740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
